Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid plus drilling decompression for early-stage femoral head necrosis
ChiCTR2000034931Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of zoledronic acid in osteonecrosis of the hip (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: collapse rate of femoral head, outcome of necrotic foci in non-collapsed cases and 1 more. Started Jul 2020; status: recruiting.
02
Drugs
zoledronic acid
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on ChiCTR2000034931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034931.